About the Rheumatic Heart Disease Session
Rheumatic heart disease (RHD) is a long-term consequence of rheumatic fever, an inflammatory disease that can develop after a strep throat or scarlet fever infection. When left untreated, the inflammation caused by rheumatic fever can damage the heart valves, leading to complications such as valve stenosis or regurgitation. While the disease was once common in many parts of the world, its prevalence has decreased significantly in developed countries due to widespread use of antibiotics to treat strep throat. However, RHD remains a major concern in low- and middle-income nations, where access to medical care and prevention programs is limited. Early detection and appropriate treatment of streptococcal throat infections are crucial in preventing the development of rheumatic heart disease.
Related Scientific Sessions at Heart Congress 2027
Why Attend the Rheumatic Heart Disease Conference 2027
Present Your Research
Oral and poster slots for original Rheumatic Heart Disease work, reviewed by the scientific committee.
Network Globally
Meet cardiologists, researchers and healthcare professionals from around the world across three days.
Get Published
Accepted abstracts are published in the conference abstract book.
Learn from Keynotes
Plenary lectures from leading voices shaping Rheumatic Heart Disease research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join Heart Congress 2027 for the Rheumatic Heart Disease track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Rheumatic Heart Disease Conference 2027 — FAQs
What is the Rheumatic Heart Disease track at Heart Congress 2027?
The Rheumatic Heart Disease track is a dedicated stream within Heart Congress 2027 covering the latest research, clinical practice and innovation in Rheumatic Heart Disease. It brings together cardiologists, cardiovascular researchers and healthcare professionals for oral presentations, posters, and discussion.
Who should attend the Rheumatic Heart Disease sessions?
Cardiologists, cardiac surgeons, cardiovascular researchers, nurses, academics, medical students and industry professionals with an interest in Rheumatic Heart Disease are all welcome — whether presenting or attending.
Can I present my research in the Rheumatic Heart Disease track?
Yes. Submit an abstract for oral or poster presentation. Abstracts are reviewed by the scientific committee before acceptance, and accepted abstracts are published in the conference abstract book.
Is virtual attendance available for Rheumatic Heart Disease sessions?
Yes. Heart Congress 2027 is a hybrid conference — attend the Rheumatic Heart Disease track in person in Rome or join live online, with on-demand access afterward.
Join the Heart Congress 2027 delegation
Rome · June 24–26, 2027· Hybrid · in-person & virtual
Attend without presenting.